期刊文献+

扩张型心肌病与Desmin及血小板活化因子乙酰水解酶基因相关性研究 被引量:2

Correlation Between Desmin Gene, Platelet-Activating Factor Acetylhydrolase Gene and Dilated Cardiomyopathy
暂未订购
导出
摘要 目的探讨中国扩张型心肌病(dilatedcardiomyopathy,DCM)人群中是否存在Desmin基因外显子8上的一个错意突变(Ile451Met)及检测血小板活化因子乙酰水解酶(platelet-activatingfactoracetylhydrolase,PAF-AH)基因G994→T错义突变发生频率,以及它们与DCM的关系。方法通过聚合酶链反应、限制性内切酶酶切、聚丙烯酰胺凝胶电泳及银染技术,结合DNA测序分析89例DCM患者和110例对照组Desmin基因及PAF-AH基因可能突变位点(Ile451Met,Val279Phe)。结果通过上述方法检测后未能发现两组中存在Desmin基因(Ile451Met)突变,PAF-AH基因突变(Val279Phe)发生频率在病例组及对照组间的差异无统计学意义(P>0.05)。结论在小样本中国成都地区扩张型心肌病患者中,未发现Desmin基因第8外显子存在Ile451Met突变,并且与PAF-AH基因突变(Val279Phe)无明显相关。 Objective To test the Missense mutation of Desmin gene (Ile451Met), the frequency of missense mutation (G^994→T) of Platelet-Activating Factor Acetylhydrolase (PAF-AH) gene, and the correlation between these mutations and dilated cardiomyopathy (DCM) in the Chinese population with DCM. Methods A case control study was conducted with 89 DCM patients and 110 healthy people (control group) participating in the study. The exon 8 of Desmin gene and exon 9 of PAF-AH gene were identified by polymerase chain reaction, restriction enzyme digestion, polyacrylamide gel electrophoresis and DNA sequencing for described mutation site of Desmin(Ile451Met) and PAF-AH (Va1279Phe). Results No mutation(Ile451Met) in Desmin gene was found in either the DCM patients or the healthy people. There was no significant difference in the frequency of PAF-AH gene mutation (Va1279Phe) between the patient and control groups (P〉0. 05). Conclusion Neither the mutation of Ile451Met in gene encoding for Desmin exon 8 nor the mutation frequency of PAF-AH gene (G^994→T) has correlation with the DCM.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2006年第3期391-394,共4页 Journal of Sichuan University(Medical Sciences)
基金 四川省科技厅应用基础项目(04JY029-078-1) 2003年度教育部"优秀青年教师资助计划" 教育部高等学校博士学科点专项科研基金(20030610032)资助
关键词 扩张型心肌病 Desmin基因 基因突变 聚合酶链反应 遗传 Dilated cardiomyopathy Desmin PAF-AH Mutation PCR Genetics
  • 相关文献

参考文献8

  • 1Richardson P, McKenna W, Vristow M, et al. Report of the 1995 world health organization/international society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation, 1996, 93(5):841-842.
  • 2Michels VV, Moll PP, Miller FA, et al. The frequency of familial dilated cardiomyopathy in a series of patient with idiopathic dilated cardiomyopathy. N Engl J Med,1992,326(2):77-82.
  • 3Li D, Tapscoft T, Gonzalez O, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation,1999;100(5):461-464.
  • 4Miyamoto Y, Akita H, Shiga N, et al. Frequency and clinical characteristics of dilated cardiomyopathy caused by desmin gene mutation in a Japanese population. European Heart Journal,2001,22(24):2284-2289.
  • 5Li Y, Huang T, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet,1995,11(4):376-381.
  • 6Ichihara S, Yamada Y, Yokota M. Association of a G^994→T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese. Circulation, 1998,98(18):1881-1885.
  • 7Bowles NE, Bowles KR, Towbin JA, et al. The "final common pathway" hypothesis and inherited cardiovascular disease the role of cytoskeletal proteins in dilated cardiomyopathy. Herz,2000; 25(3): 168-175.
  • 8Tesson F, Sylvius N, Pilotto A, et al. Epidemiology of desmin and cardiac actin gene mutations in a European population of dilated cardiomyopathy. European Heart Journal,2000,21(22):1872-1876.

同被引文献54

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部